The Kirby Institute has developed the first non-English version of its AI-driven epidemic warning tool EPIWATCH, expanding its availability in one of the world's most populous countries.
The World Health Organization has classified the EG.5 family of Omicron variants, including Eris, as ‘variants of interest’. What does that mean? And how does Eris differ to other Omicron variants?
If proven effective in future clinical trials, these therapeutics will be a key tool in the fight against COVID-19.
Project goals include improving long-term health for people living with HIV, fighting kidney disease and lessening the negative effects of chemotherapy in cancer patients.
UNSW researchers have been named as finalists in Australia’s most high-profile science awards.
Increasing treatment access and reducing undiagnosed infections is vital for combating HIV, UNSW researchers have shown.
There aren’t enough interventions for people who use drugs, new research shows.
The analysis provides crucial information on the effectiveness of updated COVID-19 boosters.
An international clinical trial has explored alternative approaches to second-line HIV therapy - with promising results.
An updated Cochrane Review suggests face masks don’t reduce the spread of COVID in the community. But there are several reasons why this conclusion is misleading.